PRESS RELEASE published on 07/20/2023 at 16:00, 3 years ago Swiss Re structures Blackstone's first indemnity catastrophe bond
PRESS RELEASE published on 07/12/2023 at 07:00, 3 years ago Swiss Re's Board of Directors proposes Jacques de Vaucleroy for election as Chairman at next AGM in April 2024
PRESS RELEASE published on 07/10/2023 at 10:00, 3 years ago Emerging Asia to drive global economic growth, says Swiss Re
PRESS RELEASE published on 06/14/2023 at 10:00, 3 years 1 month ago What if there was a shortcut through the Arctic? Swiss Re identifies new emerging risks
PRESS RELEASE published on 05/22/2023 at 10:30, 3 years 2 months ago Next wave of life expectancy gains is on the horizon, says Swiss Re report
PRESS RELEASE published on 05/04/2023 at 07:00, 3 years 2 months ago Swiss Re reports a first-quarter net income of USD 643 million
PRESS RELEASE published on 04/27/2023 at 07:00, 3 years 3 months ago Sergio P. Ermotti to step down as Swiss Re Chairman on 30 April 2023 after handover to Vice Chairman Jacques de Vaucleroy
PRESS RELEASE published on 04/25/2023 at 16:00, 3 years 3 months ago Swiss Re Reinsurance Solutions forms strategic partnership with Benekiva to create an end-to-end digital claims management solution
PRESS RELEASE published on 04/14/2023 at 07:00, 3 years 3 months ago Swiss Re publishes its 2022 Financial Condition Report
PRESS RELEASE published on 04/12/2023 at 18:15, 3 years 3 months ago Swiss Re shareholders approve all proposals at 2023 AGM
Published on 07/28/2026 at 15:00, 1 hour 52 minutes ago Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog
Published on 07/28/2026 at 14:45, 2 hours 7 minutes ago Trifecta Gold Introduces the Liam and Lois Projects, East-Central Yukon and Grants Stock Options
Published on 07/28/2026 at 14:30, 2 hours 22 minutes ago Sekur Private Data Reports 25% Month-Over-Month Increase in Average Revenue Per User as Premium Pivot Takes Hold
Published on 07/28/2026 at 14:30, 2 hours 22 minutes ago NanoViricides Awaits Approval from DR Congo Regulatory Agency for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola, Financing Completed to Support the Trial
Published on 07/28/2026 at 14:00, 2 hours 52 minutes ago Adcore Delivers Five Autonomous AI Agents, Exceeding Its Public Q2 Roadmap Commitment
Published on 07/27/2026 at 18:00, 22 hours 52 minutes ago Saint-Gobain accelerates in Asia with two targeted acquisitions
